{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:10Z","timestamp":1786988110028,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis D virus (HDV) infection accelerates liver illness progression in hepatitis B surface antigen (HBsAg)-positive individuals, yet its prevalence in Alexandria, Egypt, is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We carried out a prospective cross-sectional observational study on 158 HBsAg-positive adults attending the Alexandria University Viral Hepatitis Treatment Unit (Sept 2022\u2013Aug 2023). All underwent clinical, laboratory, and imaging assessment, and serum total anti-HDV antibodies were detected by ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Anti-HDV antibodies were detected in 19.6% (31\/158) of patients (95% CI, 13.4%-26.8%). HDV-positive patients were older (mean 50.9\u2009\u00b1\u200912.0 vs. 45.3\u2009\u00b1\u200911.6 years,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024), had higher ALT (median 38 vs. 32 U\/L,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.010) and AST (median 40 vs. 31 U\/L,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009), more frequent significant fibrosis (74.2% vs. 51.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021), and lower HBV DNA levels (median 0.04 vs. 0.70\u2009\u00d7\u200910\u00b3 IU\/mL,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017). Hepatic encephalopathy was more common across HDV-positive participants (12.9% vs. 1.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Nearly one in five HBsAg-positive patients in Alexandria, Egypt, had evidence of HDV exposure, with associations suggesting more advanced liver injury. These findings support universal HDV screening among all HBsAg-positive individuals in Egypt.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13956-6","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:54:55Z","timestamp":1786708495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence of hepatitis D among hepatitis B-infected patients attending the viral hepatitis treatment unit in Alexandria, Egypt: a prospective cross-sectional observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"Amany","family":"Elyamany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Ghazala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"3","key":"13956_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.14218\/JCTH.2015.00018","volume":"3","author":"K Giersch","year":"2015","unstructured":"Giersch K, Dandri M, Hepatitis B. Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte. J Clin Transl Hepatol. 2015;3(3):220\u20139.","journal-title":"J Clin Transl Hepatol"},{"key":"13956_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jare.2019.03.009","volume":"17","author":"N Mentha","year":"2019","unstructured":"Mentha N, Cl\u00e9ment S, Negro F, Alfaiate D. A review on hepatitis D: From virology to new therapies. J Adv Res. 2019;17:3\u201315.","journal-title":"J Adv Res"},{"issue":"3","key":"13956_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/gut.46.3.420","volume":"46","author":"G Fattovich","year":"2000","unstructured":"Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut. 2000;46(3):420\u20136.","journal-title":"Gut"},{"issue":"5","key":"13956_CR4","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jhep.2020.06.038","volume":"73","author":"D Roulot","year":"2020","unstructured":"Roulot D, Brichler S, Layese R, BenAbdesselam Z, Zoulim F, Thibault V, et al. Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta. J Hepatol. 2020;73(5):1046\u201362.","journal-title":"J Hepatol"},{"issue":"9","key":"13956_CR5","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/jgh.12217","volume":"28","author":"RG Gish","year":"2013","unstructured":"Gish RG, Yi DH, Kane S, Clark M, Mangahas M, Baqai S, et al. Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California. J Gastroenterol Hepatol. 2013;28(9):1521\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"13956_CR6","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/jvh.13577","volume":"28","author":"H Kamal","year":"2021","unstructured":"Kamal H, Fornes R, Simin J, St\u00e5l P, Duberg AS, Brusselaers N, et al. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies. J Viral Hepat. 2021;28(10):1431\u201342.","journal-title":"J Viral Hepat"},{"issue":"3","key":"13956_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jhep.2020.02.030","volume":"73","author":"D Alfaiate","year":"2020","unstructured":"Alfaiate D, Cl\u00e9ment S, Gomes D, Goossens N, Negro F. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. J Hepatol. 2020;73(3):533\u20139.","journal-title":"J Hepatol"},{"issue":"2","key":"13956_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jhepr.2019.05.001","volume":"1","author":"M Puigveh\u00ed","year":"2019","unstructured":"Puigveh\u00ed M, Moctezuma-Vel\u00e1zquez C, Villanueva A, Llovet JM. The oncogenic role of hepatitis delta virus in hepatocellular carcinoma. JHEP Rep. 2019;1(2):120\u201330.","journal-title":"JHEP Rep"},{"issue":"3","key":"13956_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","volume":"73","author":"AJ Stockdale","year":"2020","unstructured":"Stockdale AJ, Kreuels B, Henrion MYR, Giorgi E, Kyomuhangi I, de Martel C, et al. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol. 2020;73(3):523\u201332.","journal-title":"J Hepatol"},{"issue":"10","key":"13956_CR10","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","volume":"221","author":"Z Miao","year":"2020","unstructured":"Miao Z, Zhang S, Ou X, Li S, Ma Z, Wang W, et al. Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection. J Infect Dis. 2020;221(10):1677\u201387.","journal-title":"J Infect Dis"},{"issue":"3","key":"13956_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","volume":"68","author":"HY Chen","year":"2019","unstructured":"Chen HY, Shen DT, Ji DZ, Han PC, Zhang WM, Ma JF, et al. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut. 2019;68(3):512\u201321.","journal-title":"Gut"},{"issue":"6","key":"13956_CR12","first-page":"313","volume":"35","author":"A el Zayadi","year":"1988","unstructured":"el Zayadi A, Ponzetto A, Selim O, Forzani B, Lavarini C, Rizzetto M. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt. Hepatogastroenterology. 1988;35(6):313\u20135.","journal-title":"Hepatogastroenterology"},{"issue":"15","key":"13956_CR13","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1056\/NEJMcpc049016","volume":"351","author":"A Kratz","year":"2004","unstructured":"Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med. 2004;351(15):1548\u201363.","journal-title":"N Engl J Med"},{"key":"13956_CR14","first-page":"17","volume":"3","author":"S Gowda","year":"2009","unstructured":"Gowda S, Desai PB, Hull VV, Math AA, Vernekar SN, Kulkarni SS. A review on laboratory liver function tests. Pan Afr Med J. 2009;3:17.","journal-title":"Pan Afr Med J"},{"issue":"2","key":"13956_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3122\/jabfm.2014.02.130104","volume":"27","author":"J Hickner","year":"2014","unstructured":"Hickner J, Thompson PJ, Wilkinson T, Epner P, Sheehan M, Pollock AM, et al. Primary care physicians\u2019 challenges in ordering clinical laboratory tests and interpreting results. J Am Board Fam Med. 2014;27(2):268\u201374.","journal-title":"J Am Board Fam Med"},{"issue":"2","key":"13956_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpha.2011.10.001","volume":"2","author":"QY Zhang","year":"2012","unstructured":"Zhang QY, Chen H, Lin Z, Lin JM. Comparison of chemiluminescence enzyme immunoassay based on magnetic microparticles with traditional colorimetric ELISA for the detection of serum \u03b1-fetoprotein. J Pharm Anal. 2012;2(2):130\u20135.","journal-title":"J Pharm Anal"},{"key":"13956_CR17","volume-title":"Clinical Chemistry, Immunology and Laboratory Quality Control: A Comprehensive Review for Board Preparation, Certification and Clinical Practice","author":"A Dasgupta","year":"2021","unstructured":"Dasgupta A, Wahed A. Clinical Chemistry, Immunology and Laboratory Quality Control: A Comprehensive Review for Board Preparation, Certification and Clinical Practice. New York: Academic; 2021."},{"issue":"3","key":"13956_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2008.07.038","volume":"50","author":"V Svicher","year":"2009","unstructured":"Svicher V, Gori C, Trignetti M, Visca M, Micheli V, Bernassola M, et al. The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes. J Hepatol. 2009;50(3):461\u201370.","journal-title":"J Hepatol"},{"issue":"8","key":"13956_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1590\/0074-02760160119","volume":"111","author":"F Lardeux","year":"2016","unstructured":"Lardeux F, Torrico G, Aliaga C. Calculation of the ELISA\u2019s cut-off based on the change-point analysis method for detection of Trypanosoma cruzi infection in Bolivian dogs in the absence of controls. Mem Inst Oswaldo Cruz. 2016;111(8):501\u20134.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"13956_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12985-020-01355-5","volume":"17","author":"GY Lin","year":"2020","unstructured":"Lin GY, Wu YL, Wang CS, Ko CY, Chen CH, Chen PJ, et al. Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan. Virol J. 2020;17(1):76.","journal-title":"Virol J"},{"issue":"1","key":"13956_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1440-1746.1998.tb00546.x","volume":"13","author":"YH Huang","year":"1998","unstructured":"Huang YH, Wu JC, Sheng WY, Huo TI, Chang FY, Lee SD. Diagnostic value of anti-hepatitis D virus (HDV) antibodies revisited: a study of total and IgM anti-HDV compared with detection of HDV-RNA by polymerase chain reaction. J Gastroenterol Hepatol. 1998;13(1):57\u201361.","journal-title":"J Gastroenterol Hepatol"},{"key":"13956_CR22","first-page":"1","volume":"17","author":"D Dutta","year":"2021","unstructured":"Dutta D. Relevance of Child Pugh scoring system as inclusion criteria in hepatocellular carcinoma management. Japanese J Gastro Hepato. 2021;17:1\u20133.","journal-title":"Japanese J Gastro Hepato"},{"issue":"3","key":"13956_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.mric.2021.05.005","volume":"29","author":"HH Choi","year":"2021","unstructured":"Choi HH, Rodgers SK, Khurana A, Nelson LW, Kamaya A. Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma Surveillance. Magn Reson Imaging Clin N Am. 2021;29(3):279\u201390.","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"3","key":"13956_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2214\/ajr.182.3.1820643","volume":"182","author":"KH Lee","year":"2004","unstructured":"Lee KH, O\u2019Malley ME, Haider MA, Hanbidge A. Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol. 2004;182(3):643\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"13956_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/diagnostics5030383","volume":"5","author":"E Niendorf","year":"2015","unstructured":"Niendorf E, Spilseth B, Wang X, Taylor A. Contrast Enhanced MRI in the Diagnosis of HCC. Diagnostics (Basel). 2015;5(3):383\u201398.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"13956_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12876-025-03982-0","volume":"25","author":"C Wang","year":"2025","unstructured":"Wang C. Role of liver transient elastography in detecting cirrhosis with esophageal and gastric varices and evaluating variceal severity. BMC Gastroenterol. 2025;25(1):379.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"13956_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/apt.13488","volume":"43","author":"Y Li","year":"2016","unstructured":"Li Y, Huang YS, Wang ZZ, Yang ZR, Sun F, Zhan SY, Liu XE, Zhuang H. Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2016;43(4):458\u201369.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"13956_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hep.31055","volume":"72","author":"MI Elsaid","year":"2020","unstructured":"Elsaid MI, Li Y, John T, Narayanan N, Catalano C, Rustgi VK. Economic and Health Care Burdens of Hepatitis Delta: A Study of Commercially Insured Adults in the United States. Hepatology. 2020;72(2):399\u2013411.","journal-title":"Hepatology"},{"issue":"1","key":"13956_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/JCMA.0000000000000606","volume":"85","author":"TE Chang","year":"2022","unstructured":"Chang TE, Su CW, Huang YS, Huang YH, Hou MC, Wu JC. Hepatitis D virus dual infection increased the risk of hepatocellular carcinoma compared with hepatitis B virus mono infection: A meta-analysis. J Chin Med Assoc. 2022;85(1):30\u201341.","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"13956_CR30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/HEP.0000000000000642","volume":"79","author":"RG Gish","year":"2024","unstructured":"Gish RG, Wong RJ, Di Tanna GL, Kaushik A, Kim C, Smith NJ, et al. Association of hepatitis delta virus with liver morbidity and mortality: A systematic literature review and meta-analysis. Hepatology. 2024;79(5):1129\u201340.","journal-title":"Hepatology"},{"issue":"2","key":"13956_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","volume":"79","author":"European Association for the Study of the Liver (EASL)","year":"2023","unstructured":"European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on hepatitis delta virus. J Hepatol. 2023;79(2):433\u201360.","journal-title":"J Hepatol"},{"issue":"1","key":"13956_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1\u201398.","journal-title":"Hepatol Int"},{"key":"13956_CR33","doi-asserted-by":"crossref","unstructured":"Ghany Marc G, Pan Calvin Q, Lok Anna S, Feld Jordan J, Lim Joseph K, Wang, Su H, et al. AASLD\/IDSA practice guideline on treatment of chronic hepatitis B. Hepatology. 2025.","DOI":"10.1097\/HEP.0000000000001549"},{"issue":"10","key":"13956_CR34","doi-asserted-by":"publisher","first-page":"100547","DOI":"10.1016\/j.jhepr.2022.100547","volume":"4","author":"A Palom","year":"2022","unstructured":"Palom A, Rando-Segura A, Vico J, Pac\u00edn B, Vargas E, Barreira-D\u00edaz A, et al. Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D. JHEP Rep. 2022;4(10):100547.","journal-title":"JHEP Rep"},{"issue":"1","key":"13956_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/liv.15746","volume":"44","author":"V Cossiga","year":"2024","unstructured":"Cossiga V, Brusa S, Montalti R, De Conte A, Jannuzzi G, Ranieri L, et al. Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection. Liver Int. 2024;44(1):148\u201354.","journal-title":"Liver Int"},{"issue":"1\u20132","key":"13956_CR36","first-page":"147","volume":"67","author":"MA Darwish","year":"1992","unstructured":"Darwish MA, Shaker M, Raslan OS, Abdel-Raouf T. Delta virus infection in Egypt. J Egypt Public Health Assoc. 1992;67(1\u20132):147\u201361.","journal-title":"J Egypt Public Health Assoc"},{"key":"13956_CR37","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/S1201-9712(10)60168-3","volume":"14","author":"S Zaki","year":"2010","unstructured":"Zaki S, Abou Khatwa M, Mikhail H. pp-100 prevalence of infection with delta virus in patients positive for hepatitis B surface antigen. Int J Infect Dis. 2010;14:S55.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"13956_CR38","first-page":"49","volume":"5","author":"M Ahmed","year":"2016","unstructured":"Ahmed M. Study of the impact of hepatitis D virus infection on chronic hepatitis B virus patients in Egypt. Int J Curr Microbiol Appl Sci. 2016;5(2):49\u201358.","journal-title":"Int J Curr Microbiol Appl Sci"},{"issue":"5","key":"13956_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/jmv.24412","volume":"88","author":"R Fouad","year":"2016","unstructured":"Fouad R, Abdo M, Eldeen HG, Sabry D, Atef M, Ahmed R, et al. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D. J Med Virol. 2016;88(5):837\u201342.","journal-title":"J Med Virol"},{"issue":"1","key":"13956_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/jvh.13621","volume":"29","author":"W Elzefzafy","year":"2022","unstructured":"Elzefzafy W, Soliman R, Saleh L, Mahmoud S, Makhlouf NA, Shiha G, et al. Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta, Egypt. J Viral Hepat. 2022;29(1):87\u201390.","journal-title":"J Viral Hepat"},{"issue":"3","key":"13956_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jiph.2018.12.001","volume":"12","author":"NA Makhlouf","year":"2019","unstructured":"Makhlouf NA, Morsy KH, Mahmoud AA. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features. J Infect Public Health. 2019;12(3):350\u20136.","journal-title":"J Infect Public Health"},{"issue":"8","key":"13956_CR42","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/jmv.23336","volume":"84","author":"W Mansour","year":"2012","unstructured":"Mansour W, Malick FZ, Sidiya A, Ishagh E, Chekaraou MA, Veillon P, et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol. 2012;84(8):1186\u201398.","journal-title":"J Med Virol"},{"issue":"9","key":"13956_CR43","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1111\/liv.15638","volume":"43","author":"G Papatheodoridis","year":"2023","unstructured":"Papatheodoridis G, Mimidis K, Manolakopoulos S, Triantos C, Vlachogiannakos I, Veretanos C, et al. HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients. Liver Int. 2023;43(9):1879\u201389.","journal-title":"Liver Int"},{"issue":"8","key":"13956_CR44","first-page":"e43362","volume":"15","author":"Z Abbas","year":"2023","unstructured":"Abbas Z, Abbas M. An Insight Into the Factors Affecting the Prevalence and Natural History of Hepatitis D. Cureus. 2023;15(8):e43362.","journal-title":"Cureus"},{"issue":"8","key":"13956_CR45","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s10620-020-06499-6","volume":"66","author":"TL Fong","year":"2021","unstructured":"Fong TL, Lee BT, Chang M, Nasanbayar K, Tsogtoo E, Boldbaatar D, et al. High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California. Dig Dis Sci. 2021;66(8):2833\u20139.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"13956_CR46","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1365-2893.2010.01329.x","volume":"18","author":"IH Bahcecioglu","year":"2011","unstructured":"Bahcecioglu IH, Aygun C, Gozel N, Poyrazoglu OK, Bulut Y, Yalniz M. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider. J Viral Hepat. 2011;18(7):518\u201324.","journal-title":"J Viral Hepat"},{"issue":"6","key":"13956_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1684-1182(10)60080-1","volume":"43","author":"AH Mohammad Alizadeh","year":"2010","unstructured":"Mohammad Alizadeh AH, Ranjbar M, Tehrani AS, Keramat F, Mamani M, Rezazadeh M, et al. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran. J Microbiol Immunol Infect. 2010;43(6):519\u201323.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"13956_CR48","doi-asserted-by":"publisher","first-page":"100461","DOI":"10.1016\/j.jhepr.2022.100461","volume":"4","author":"C Osiowy","year":"2022","unstructured":"Osiowy C, Swidinsky K, Haylock-Jacobs S, Sadler MD, Fung S, Wong D, et al. Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada. JHEP Rep. 2022;4(5):100461.","journal-title":"JHEP Rep"},{"issue":"3","key":"13956_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/jvh.13779","volume":"30","author":"R Nathani","year":"2023","unstructured":"Nathani R, Leibowitz R, Giri D, Villarroel C, Salman S, Sehmbhi M, et al. The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection. J Viral Hepat. 2023;30(3):195\u2013200.","journal-title":"J Viral Hepat"},{"issue":"3","key":"13956_CR50","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s12013-014-0137-8","volume":"70","author":"XH Gu","year":"2014","unstructured":"Gu XH, Chen Z, Dai RY, Zhang ML, Tang HM, Chen LB, et al. Analysis on the clinical features of 507 HDV-infected patients. Cell Biochem Biophys. 2014;70(3):1829\u201332.","journal-title":"Cell Biochem Biophys"},{"issue":"8","key":"13956_CR51","first-page":"503","volume":"41","author":"P Gupta","year":"1993","unstructured":"Gupta P, Kar P, Chakravarty A, Jain A. Delta virus infection in cirrhotics in a north Indian hospital. J Assoc Physicians India. 1993;41(8):503\u20134.","journal-title":"J Assoc Physicians India"},{"issue":"1","key":"13956_CR52","doi-asserted-by":"publisher","first-page":"22633","DOI":"10.1038\/s41598-023-49819-2","volume":"13","author":"P Ananchuensook","year":"2023","unstructured":"Ananchuensook P, Suksawatamnuay S, Thaimai P, Siripon N, Sriphoosanaphan S, Thanapirom K, et al. Prevalence of hepatitis D virus infection among patients with chronic hepatitis B infection in a tertiary care centre in Thailand. Sci Rep. 2023;13(1):22633.","journal-title":"Sci Rep"},{"issue":"5","key":"13956_CR53","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/HEP.0000000000000687","volume":"79","author":"RG Gish","year":"2024","unstructured":"Gish RG, Jacobson IM, Lim JK, Waters-Banker C, Kaushik A, Kim C, et al. Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States: An analysis of the All-Payer Claims Database. Hepatology. 2024;79(5):1117\u201328.","journal-title":"Hepatology"},{"issue":"2","key":"13956_CR54","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/liv.15804","volume":"44","author":"A d\u2019Arminio Monforte","year":"2024","unstructured":"d\u2019Arminio Monforte A, Tavelli A, Salpini R, Piermatteo L, D\u2019Anna S, Carrara S, et al. Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort. Liver Int. 2024;44(2):603\u201313. 144.","journal-title":"Liver Int"},{"issue":"4","key":"13956_CR55","doi-asserted-by":"publisher","first-page":"e0250347","DOI":"10.1371\/journal.pone.0250347","volume":"16","author":"J Barbosa","year":"2021","unstructured":"Barbosa J, Sahli R, Aubert V, Chaouch A, Moradpour D, Fraga M. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center. PLoS ONE. 2021;16(4):e0250347.","journal-title":"PLoS ONE"},{"issue":"6","key":"13956_CR56","first-page":"107963","volume":"27","author":"Z Abbas","year":"2025","unstructured":"Abbas Z, Abbas M. Hope on the horizon: Emerging therapies for hepatitis D. World J Hepatol. 2025;27(6):107963.","journal-title":"World J Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13956-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:01:45Z","timestamp":1786986105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13956-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13956"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13956-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed written consent was obtained from each patient. This study had been approved by the Ethics Committee of Alexandria faculty of medicine (IRB NO: 00012098, serial number: 0107523) and conforms to the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1507"}}